Clinical Trial Update: Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for cyclosporine ophthalmic solution and suspension in dry eye syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• Cyclosporine ophthalmic solution (cyclosporine)
• Cyclosporine ophthalmic suspension (cyclosporine)

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED